Clinical trial finds three new ways to treat drug-resistant tuberculosis
The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.